|CrossRef Text and Data Mining|
|Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.|
|Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir|
|Seung Bum Lee, Joonho Jeong, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung-Jo Bang, Jung Woo Shin, Bo Ryung Park, Eun Ji Park, Neung Hwa Park|
|Clin Mol Hepatol. 2020;26(3):364-375. Published online 2020 May 29 DOI: https://doi.org/10.3350/cmh.2020.0012|
Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
Low-level viremia in patients with chronic hepatitis B receiving entecavir, tenofovir and tenofovir alafenamide
Lamivudine is not effective in the treatment of non-cirrhotic HBeAg (−) chronic hepatitis B patients with low level viremia
Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
Low-level viremia in hepatitis b patients on antiviral treatment: Can we ignore it?
P.086 Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
Combination therapy in HBeAg-negative chronic hepatitis B patients with low-level viremia to nucleos (tide) analogues
At least 90% long-term adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir
|This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.|